FDA - Public consultation on Decentralized Clinical Trials for drugs, Biological Products, and Devices (Catapult's regulatory round-up May)
Fiche du document
Auteur
Date
21 février 2024
Discipline
Types de document
Périmètre
Identifiant
- doi: 10.58079/vvhx
Source
Organisation
Licence
info:eu-repo/semantics/openAccess
Sujets proches
Medications Medicaments Prescription drugs Medicines (Drugs) Pharmaceuticals Medicine (Drugs) Coats of arms Devices Arms, Coats of Heraldic devices Controlled clinical trials Randomized clinical trials Trials, Clinical Patient trials of new treatments Products, Biological BioproductsCiter ce document
adelage, « FDA - Public consultation on Decentralized Clinical Trials for drugs, Biological Products, and Devices (Catapult's regulatory round-up May) », ELSIBI, ID : 10.58079/vvhx
Métriques
Partage / Export
Résumé
Public consultation for a draft guidance on "Decentralized Clinical Trials for Drugs, Biological Products, and Devices" Published on the 2nd of June 2023. Read the entire regulatory round-up for the month of May published and curated by Catapult here.